Light Mode
$24.71 ↓ -0.47 (-1.87%) Trading Down from the previous close of $25.18
-0.73 (-2.82%) / 6M
Momentum, market sentiment, and recent alerts
PRCT reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is -9.8%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.